Truist Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.95M | Buy |
|
|||||
|
2025
Q2 | $1.31M | Buy |
|
|||||
|
2025
Q1 | $979K | Sell |
|
|||||
|
2024
Q4 | $1.03M | Buy |
|
|||||
|
2024
Q3 | $511K | Buy |
|
|||||
|
2024
Q2 | $420K | Sell |
|
|||||
|
2024
Q1 | $351K | Sell |
|
|||||
|
2023
Q4 | $474K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $266K | Sell |
|
|||||
|
2022
Q4 | $349K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $729K | Sell |
|
|||||
|
2022
Q1 | $1.13M | Sell |
|
|||||
|
2021
Q4 | $1.29M | Buy |
|
|||||
|
2021
Q3 | $1.25M | Buy |
|
|||||
|
2021
Q2 | $1.11M | Buy |
|
|||||
|
2021
Q1 | $808K | Buy |
|
|||||
|
2020
Q4 | $228K | Buy |
|
|||||
|
2020
Q3 | $201K | Sell |
|
|||||
|
2020
Q2 | $262K | Sell |
|
|||||
|
2020
Q1 | $211K | Sell |
|
|||||
|
2019
Q4 | $245K | Buy |
|